Published on
16:48 GMT
mRNA Flu Vaccine Faces FDA Verdict: Approval Alone Won't Mean Coverage for Seniors
Today is the deadline the FDA set itself to issue a verdict on the first mRNA-based seasonal influenza vaccine in American history — but adults 50 and older who are hoping to switch to Moderna's mFlusiva for the coming flu season should understand that …
Source:
Tech Times
-
Neutral
